Biovica International AB OMXSTO:BIOVIC_B:
REFOCUSES US COMMERCIAL STRATEGY AND TERMINATES AGREEMENT WITH TEMPUS AI
COLLABORATION WITH TEMPUS DID NOT RESULT IN COMMERCIAL LAUNCH OR REVENUE
TERMINATION DOES NOT AFFECT SAN DIEGO LAB, US CLINICAL ACTIVITIES, OR PHARMA SERVICES